trending Market Intelligence /marketintelligence/en/news-insights/trending/tPupTwkRkbKGgXg9ZhssZQ2 content esgSubNav
In This List

Concert Pharmaceuticals CFO to quit

Blog

Funding Social and Affordable Housing: A Credit Perspective

Blog

Global M&A By the Numbers: Q2 2021

Blog

Global Capital Markets & SPAC Activity – H1 2021

Blog

Banking Essentials Newsletter: July Edition - Part 3


Concert Pharmaceuticals CFO to quit

Concert Pharmaceuticals Inc. CFO Ryan Daws will leave the company in June to join Baird as its managing director of life sciences and biotech.

Daws will continue to consult with Concert and help the company close the sale of its investigational cystic fibrosis drug CTP-656 to Vertex Pharmaceuticals Inc.

The company said it has initiated a search for a new CFO.